Log in to save to my catalogue

Exploring the NK cell platform for cancer immunotherapy

Exploring the NK cell platform for cancer immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8316981

Exploring the NK cell platform for cancer immunotherapy

About this item

Full title

Exploring the NK cell platform for cancer immunotherapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Clinical oncology, 2021-02, Vol.18 (2), p.85-100

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system that are capable of killing virally infected and/or cancerous cells. Nearly 20 years ago, NK cell-mediated immunotherapy emerged as a safe and effective treatment approach for patients with advanced-stage leukaemia. Subsequently, the field of NK cell-based cancer therap...

Alternative Titles

Full title

Exploring the NK cell platform for cancer immunotherapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8316981

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8316981

Other Identifiers

ISSN

1759-4774

E-ISSN

1759-4782

DOI

10.1038/s41571-020-0426-7

How to access this item